These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28373814)

  • 1. Myeloid-derived suppressor cells in gliomas.
    Gieryng A; Kaminska B
    Contemp Oncol (Pozn); 2016; 20(5):345-351. PubMed ID: 28373814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
    Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
    Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression.
    Ma T; Su G; Wu Q; Shen M; Feng X; Zhang Z
    Mol Biol Rep; 2024 Jan; 51(1):235. PubMed ID: 38282090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in glioma's microenvironment.
    Chen H; Li M; Guo Y; Zhong Y; He Z; Xu Y; Zou J
    Innov Surg Sci; 2020 Dec; 5(3-4):20190001. PubMed ID: 33511267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS macrophages and peripheral myeloid cells in brain tumours.
    Glass R; Synowitz M
    Acta Neuropathol; 2014 Sep; 128(3):347-62. PubMed ID: 24722970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunosuppressive microenvironment of malignant gliomas].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.
    Kohanbash G; Okada H
    Immunol Invest; 2012; 41(6-7):658-79. PubMed ID: 23017140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
    Wilkerson A; Kim J; Huang AY; Zhang M
    Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis.
    DiVita Dean B; Wildes T; Dean J; Yegorov O; Yang C; Shin D; Francis C; Figg JW; Sebastian M; Font LF; Jin D; Reid A; Moore G; Fernandez B; Wummer B; Kuizon C; Mitchell D; Flores CT
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H
    Xie Y; Zhang Y; Wei X; Zhou C; Huang Y; Zhu X; Chen Y; Wen H; Huang X; Lin J; Wang Z; Ren Y; Fan B; Deng X; Tan W; Wang C
    Front Pharmacol; 2020; 11():16. PubMed ID: 32140106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and local immunosuppression in glioblastoma and its prognostic significance.
    Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP
    Front Immunol; 2024; 15():1326753. PubMed ID: 38481999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Myeloid Cells in GBM Immunosuppression.
    Lin YJ; Wu CY; Wu JY; Lim M
    Front Immunol; 2022; 13():887781. PubMed ID: 35711434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
    Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
    Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.
    Wurdinger T; Deumelandt K; van der Vliet HJ; Wesseling P; de Gruijl TD
    Biochim Biophys Acta; 2014 Dec; 1846(2):560-75. PubMed ID: 25453365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor infiltrating immune cells in gliomas and meningiomas.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.